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Introduction. An increasing number of studies are utilizing differentmagnetic resonance (MR)methods to quantify bonemarrow fat
due to its potential role in osteoporosis. Our aim is to compare the measurements of bonemarrow fat among T1-weightedmagnetic
resonance imaging (MRI), modified Dixon method (also called fat fraction MRI (FFMRI)), and magnetic resonance spectroscopy
(MRS). Methods. Contiguous MRI scans were acquired in 27 Caucasian postmenopausal women with a modified Dixon method
(i.e., FFMRI). Bone marrow adipose tissue (BMAT) of T1-weighted MRI and bone marrow fat fraction of the L3 vertebra and
femoral necks were quantified using SliceOmatic andMatlab. MRS was also acquired at the L3 vertebra. Results. Correlation among
the three MR methods measured bone marrow fat fraction and BMAT ranges from 0.78 to 0.88 (𝑃 < 0.001) in the L3 vertebra.
Correlation between BMAT measured by T1-weighted MRI and bone marrow fat fraction measured by modified FFMRI is 0.86
(𝑃 < 0.001) in femoral necks.Conclusion.There are good correlations among T1-weightedMRI, FFMRI, andMRS for bonemarrow
fat quantification. The inhomogeneous distribution of bone marrow fat, the threshold segmentation of the T1-weighted MRI, and
the ambiguity of the FFMRI may partially explain the difference among the three methods.
1. Introduction
Recent studies revealed a negative relationship between bone
marrow fat and bone mineral density [1–10]. These studies,
along with the cellular level evidences [6, 11–13], suggest that
bone marrow fat might play a role in the pathogenesis of
osteoporosis [7, 12, 14].
Previous studies have used different methods to measure
bone marrow fat. Among the magnetic resonance methods,
there are T1-weighted magnetic resonance imaging (MRI),
magnetic resonance spectroscopy (MRS), andDixonmethod.
Each method has its comparative strengths and weaknesses.
The T1-weightedMRI is a conventional practice that is famil-
iar to all MR technologists and is therefore not technically
demanding in terms of acquisition. T1-weighted MRI also
requires less acquisition time than the Dixon method. The
Dixon method, also called the water-fat imaging method,
fat-water imaging method, or fat fraction MRI (FFMRI),
represents a category of magnetic resonance methods that
generates water and fat images. So far, there is no consensus
on the naming of this group ofmethods, and for consistency’s
sake we use FFMRI in the present paper. MRS methods are
considered the golden standard in measuring tissue fat but
require the technician to prescribe the volume of interest—
MRS box in the exact desired location. Consequently, the
acquisition of MRS is relatively technical demanding.
Although T1-weighted MRI, MRS, and FFMRI methods
have been compared in measuring subcutaneous adipose
tissue, visceral adipose tissue, organ fat (i.e., liver), it is impor-
tant to compare these methods in measuring bone marrow
fat for the following reasons: fat fraction of subcutaneous
and visceral adipose tissue is high (i.e, ∼80%), while fat
fraction for liver fat is lower (i.e., <50%); in previous results,
comparisons do not cover the full range of fat fraction. In
addition, fat within subcutaneous and visceral adipose tissue
and liver is usually homogenously distributed. Conversely,
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bone marrow fat can distribute inhomogeneously, and its
fat fraction can range from 0 to 80% depending on the
specific imaging pixel’s composition of red marrow and
yellow marrow in the pixel [15]. Therefore, comparisons of
different MR methods in measuring subcutaneous, visceral
adipose tissue or liver fat cannot necessarily be generalized to
bone marrow fat measurement. The present report compares
T1-weighted MRI, MRS, and FFMRI methods for measuring
marrow fat in the L3 vertebra and femoral necks in a group
of postmenopausal women.
2. Methods
2.1. Protocol and Design. A total of 27 Caucasian post-
menopausal women (age ≥ 50 yrs, BMI 17.4–37.9 kg/m2) were
recruited for the present study. All subjects were established
as healthy and completed a medical history screening. Sub-
jects were excluded from undergoing MRI if they had con-
traindications toMRI such asmetal implants, claustrophobia,
or weight greater than 300 lbs as per specifications of the
scanner manufacturers.
2.2. Magnetic Resonance Imaging
2.2.1. Fat Fraction MRI. Whole-body MRI scans were
acquired, as previously reported [16], using a 1.5 T Sigma
“LX” system (General Electric, Milwaukee, WI, USA). The
protocol involved acquisition of 10mm thick axial images
contiguously of the whole body with a matrix of 256 ×
160. Imaging is performed by using a breath-hold dual-
echo spoiled gradient-recalled echo sequence (repetition
time/echo time (TR/TE), 150ms/2.1ms, 4.4ms) acquired
with flip angles of 70∘ and then 20∘ to provide T1-weighted
and intermediate-weighted images, respectively [16]. A third
T1-weighted dual-echo gradient-echo breath-hold gradient-
recalled echo sequence (TR/TE, 200ms/4.6ms, 9.2ms; flip
angle, 70∘) is also performed to calculate T2∗. The percentage
of bone marrow fat is estimated from both sets of images,
and T2∗ correction is applied. The dual-flip angle images
are used to identify whether water or fat is the dominant
constituent as previously described [16]. The images were
postprocessed in Matlab (MathWorks Inc., Natick, MA,
USA) to calculate fat fraction. Bone regions were manually
analyzed at the Image Analysis Lab in the New York Obesity
Nutrition Research Center by trained, quality-controlled,
and cross-validated technicians using image analysis software
(SliceOmatic, Tomovision Inc., Montreal, Canada).The bone
regions for fat fraction calculation in the present study
include the whole L3 vertebra and the femoral neck regions
that match the “total hip” regions of the dual-energy X-ray
absorptiometry scan of the subject (Figure 1). The intra- and
interobserver CV for FFMRI analysis are 0.9% and 2.2%.
2.2.2. T1-Weighted MRI. BMAT of the L3 and femoral necks
on T1-weighted MRI (TR/TE, 150ms/4.4ms, flip angle,
70∘) was segmented at the Image Analysis Laboratory by
trained, quality-controlled, and cross-validated technicians
using image analysis software (SliceOmatic, Tomovision Inc.,
“Total hip” region 
Figure 1: Dual-energy X-ray absorptiometry total hip scan region,
which is the sum of the rectangle and triangles and is also the region
we used for bone marrow fat quantification of the femoral necks in
the present study.
Montreal, Canada). The threshold for BMAT segmentation
onT1-weightedMRIwas set at the same level as subcutaneous
adipose tissue on the grey scale. The reader first sets the
threshold that best segments subcutaneous adipose tissue
on the grey scale [2–4, 17–19], then that threshold is used
in the same image to segment BMAT. In the SliceOmatic
software package, the segmentation threshold can be freely
adjusted and the analyst can view the “preview” of sub-
cutaneous adipose tissue segmentation, which is transpar-
ently overlaid on the grey image. When the “preview” of
the segmentation best matched the subcutaneous adipose
tissue, the corresponding threshold was determined as the
threshold to segment BMAT. Tissue compartment volume
was calculated as previously described [20]. The intra- and
interobserver CV for T1-weighted MRI analysis are 1.0% and
2.6%.
2.3. Magnetic Resonance Spectroscopy. Spine phase-array coil
was used for standard PRESS sequence (P.A. Bottomley, US
Patent 4480 228 (1984)) MRS acquisition [21]. A PRESS box
with dimensions w/2⋅d/2⋅h/2 cm3 was located centrally in the
L3 vertebral body (TR/TE 3000/25) [21, 22]. Fat fraction was
calculated after spectra are processed by jMRUI (available
at http://www.mrui.uab.es/mrui/mrui Overview.shtml) [21,
22]. Manually selected resonance frequency and line width of
water (4.65 ppm) and fat (1.3 ppm) peakswere used as starting
values in the nonlinear least squares fitting algorithm. Fat
fraction, defined as the relative fat signal intensity amplitude
in terms of a percentage of total signal intensity amplitude
(𝑆fat and 𝑆water), was calculated according to the following
equation [6]: Fat fraction = 𝑆fat/(𝑆fat + 𝑆water). The intra- and
interobserver CV for MRS are both 0%, due to the automatic
process of the algorithm.
2.4. Statistical Methods. Pearson correlation coefficients
among bone marrow fat measurements of different methods
were calculated for the L3 vertebra and femoral necks. When
necessary, variable values were mathematically transformed
to normalize the residual distributions. Log transformations
were applied initially and followed by Box-Cox transforma-
tions if necessary [23].
All statistical analyses were carried out using SAS 9.2
package (SAS Institute. Inc., Cary, NC, USA). Two-tailed
(𝛼 = 0.05) tests of significance were used.
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3. Results
3.1. Descriptive Statistics. All subjects (𝑛 = 27) were post-
menopausal Caucasian women and ranged in age from 51 to
61 years (mean ± SD, 55.2 ± 3.3 years). BMI ranged from 17.8
to 37.9 kg/m2 (mean ± SD, 24.2 ± 4.9 kg/m2).
3.2. Relationship of BoneMarrow FatMeasurement among T1-
Weighted MRI, MRS, and FFMRI in L3 Vertebra. For bone
marrow fat measurement in the L3 vertebra, the correlation
between Box-Cox-transformed T1-weighted MRI and MRS
is 0.88 (𝑃 < 0.001) (Figure 2(a)).The correlation between T1-
weightedMRI andFFMRIwas 0.79 (𝑃 < 0.001) (Figure 2(b)).
The correlation between MRS and FFMRI was 0.78 (𝑃 <
0.001) (Figure 2(c)).We further located the region on FFMRI
that bestmatched theMRS box; the correlation betweenMRS
and FFMRI improved to 0.86 (𝑃 = 0.004) (plot not shown).
3.3. Relationship of Bone Marrow Fat Measurement among
T1-Weighted MRI and FFMRI in Femoral Necks. For bone
marrow fat measurement in femoral necks, the correla-
tion between Box-Cox-transformed T1-weighted MRI and
FFMRI was 0.86 (𝑃 < 0.001) (Figure 2(d)). MRS was not
acquired in the femoral necks.
4. Discussion
This study compared bone marrow fat measured by three
magnetic resonance methods: T1-weighted MRI, MRS, and
FFMRI. We have shown good correlations among the three
methods.We chose the L3 vertebra and femoral neck because
(1) these are the locations that are most frequently used
to measure bone marrow fat; (2) a major interest in bone
marrow fat measurement is attributed to its relationship
with osteoporosis; femoral neck and lumbar spine are the
locations used for the diagnosis of osteoporosis. We did not
do absolute comparison among the threemagnetic resonance
methods because the scales of the results of these methods
were not the same. In addition, T1-weighted MRI measures
adipose tissue amount, while MRS and FFMRI measured fat
fraction. Although we used these terms interchangeably, fat
and adipose tissue are not the same components [24]. Fat
makes up ∼80% of adipose tissue, with the rest as water,
proteins, minerals, and so forth.
The discrepancy among the three methods can be
attributed to several factors. First, MRS measures ∼1/8 (i.e.,
w/2⋅d/2⋅h/2) of the total volume of the L3 vertebra, and
the MRS volume of interest is located at the center of the
vertebra. On the other hand, T1-weighted MRI and FFMRI
both measure the entire L3 vertebra. If the distribution
of adipose tissue in the cavity of the L3 vertebra is not
homogeneous, fat fraction of MRS may not reflect that of
the entire vertebra [15]. When we calculated fat fraction on
FFMRI in the region that best matches the MRS box region,
the correlation between FFMRI and MRS improved (i.e., 𝑟 =
0.86 versus 0.78, 𝑃 = 0.004). However, because MRI was
acquired at 1 cm slice thickness, and the L3 vertebra had a
height of 2.4–2.9 cm (measured at the center of the vertebra)
in this study, FFMRI was subjected to partial volume effect.
Another error source of FFMRI was due to the miscalcula-
tions at approximately 45% fat content. The FFMRI method
use of in-phase and out-of-phase gradient-echo MR imaging
was performed with dual-flip angles (70∘, 20∘) to resolve
ambiguity of the dominant constituent (i.e., water or fat).
Therewere algorithmicmiscalculations at approximately 45%
fat content because of crossover of estimated fat curves [16].
Therefore, pixels of approximately 45% fat content could have
been influenced. It should be noted that there are many
versions of FFMRI methods available and error source of
thesemethodsmay be different from the FFMRImethodused
in the present study both qualitatively and quantitatively [25–
27].
The error source of T1-weighted MRI can be attributed
both to the partial volume effect of MRI and to the single
threshold T1-weighted MRI method being semiquantitative.
Only image pixels containing bone marrow adipose tissue
that reach a certain thresholdwere quantified as BMATonT1-
weighted MRI. The T1-weighted MRI method that was used
in the present study has not only been validated for quantify-
ing regional adipose tissue volume [28, 29] but has also been
widely applied to adipose tissue measurement and serves as a
reference method for adipose tissue quantification [30–36].
However, bone marrow fat pixels below the threshold for
subcutaneous adipose tissue were not quantified as BMAT in
the present study.
4.1. Limitations and Future Directions. FFMRI is a fast evolv-
ing field, and there are newer water-fat imaging methods
available now [25–27]. The present study only tested one
version of the FFMRI methods and the limitation of this
version may not necessarily apply to other FFMRI methods.
The advantage of this method is that it only uses sequences
that are commercially available on almost all MRI scanners.
Therefore, this method may be used in multicenter, large
clinical trials. On the other hand, most-recently-developed
FFMRI methods that are only available on certain MRI
scanners may be used for smaller-scale studies that require
high accuracy. Future studiesmay usemore advanced FFMRI
methods to quantify BMAT and to compare with MRS
in quantifying bone marrow fat. Future studies may also
evaluate how repositioning of the subject would influence
the agreement of bone marrow fat quantification by different
methods.
5. Conclusions
There is a good correlation among bonemarrow fatmeasured
by T1-weightedMRI, FFMRI, andMRS.The inhomogeneous
distribution of bone marrow fat, the threshold segmentation
of the T1-weighted MRI, and the ambiguity of FFMRI may
partially explain the difference among the three methods in
measuring BMAT.
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Figure 2: (a) Correlation between BMATmeasured by T1-weighted MRI (T1-WMRI) and bone marrow fat fraction (FF) measured by MRS
in L3-vertebra; (b) correlation between BMAT measured by fat fraction MRI (FFMRI) and bone marrow fat fraction measured by MRS in
L3-vertebra; (c) correlation between BMAT measured by T1-weighted MRI and bone marrow FF measured by FFMRI in L3-vertebra; (d)
correlation between BMAT measured by T1-weighted MRI and bone marrow FF measured by FFMRI in femoral necks.
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